Registry for patients with severe asthma in Canada
International Severe Asthma Registry: Canadian Cohort
This study is collecting health information from people with severe asthma in Canada to see how they respond to treatments and improve their care over the next five years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 714 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of British Columbia Academic / other |
| Locations | 12 sites (Edmonton, Alberta and 11 other locations) |
| Trial ID | NCT04045587 on ClinicalTrials.gov |
What this trial studies
The International Severe Asthma Registry aims to improve the care of individuals with severe asthma by collecting detailed health and treatment information from participants over five years. This observational study will gather anonymized longitudinal data through medical chart reviews and participant interviews at multiple Canadian sites. The collected data will help researchers understand severe asthma better and develop improved treatment strategies. Participants will be followed annually to track their progress and treatment responses.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are receiving treatment for severe asthma according to GINA guidelines.
Not a fit: Patients with mild to moderate asthma will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to enhanced treatment options and better management strategies for patients with severe asthma.
How similar studies have performed: Other similar registries have shown success in improving asthma management and treatment outcomes, indicating the potential effectiveness of this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants 18 years or older * Participants receiving treatment according to GINA Step 5 or uncontrolled in GINA Step 4 (uncontrolled is defined as having severe asthma symptoms or frequent exacerbations) Exclusion Criteria: -Participants with mild to moderate asthma
Where this trial is running
Edmonton, Alberta and 11 other locations
- University of Alberta — Edmonton, Alberta, Canada (Recruiting)
- Synergy MD Specialty Group — Edmonton, Alberta, Canada (Recruiting)
- University of British Columbia — Vancouver, British Columbia, Canada (Recruiting)
- University of British Columbia — Vancouver, British Columbia, Canada (Recruiting)
- Kingston General Hospital — Kingston, Ontario, Canada (Recruiting)
- University of Western Ontario — London, Ontario, Canada (Not_yet_recruiting)
- The Ottawa Hospital — Ottawa, Ontario, Canada (Recruiting)
- Inspiration Research Limited — Toronto, Ontario, Canada (Recruiting)
- McGill University — Montreal, Quebec, Canada (Not_yet_recruiting)
- Université de Sherbrooke — Sherbrooke, Quebec, Canada (Recruiting)
- Université Laval — Quebéc City, Quebéc, Canada (Recruiting)
- University of Saskatchewan — Saskatoon, Saskatchewan, Canada (Active_not_recruiting)
Study contacts
- Principal investigator: Celine Bergeron — University of British Columbia
- Study coordinator: Shelley Abercromby
- Email: Shelley.Abercromby@vch.ca
- Phone: (604) 875-4111
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.